-
Young Adults Still Love To Tan. These Tactics Could Get Gen Z To Be Safer in the Sun, Research Finds
Tanning is popular among Gen Z, despite the skin cancer risks. Cancer prevention researcher Kenneth Tercyak, PhD, shares strategies to get young adults to listen to advice on sun safety.
Category: Lombardi Stories
-
Despite Medicare Coverage, Many Cancer Patients Still Do Not Receive Testing That Guides Treatment Options
While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the most effective treatment for their tumor, many Medicare beneficiaries with cancer are still not receiving next-generation sequencing, according to a new analysis by Georgetown University researchers.
Category: News Release
-
From Bowerbirds to Global Cancer Research: Christopher Loffredo Looks Back on a Four-Decade Career
Georgetown Lombardi member Christopher Loffredo, PhD, has cultivated a career that has taken him from zoology to hospitals in Egypt, villages in Thailand, nuclear facilities in Russia, and cancer prevention programs in Brazil and Eswatini. He reflected on his experiences on the occasion of his valedictory lecture ahead of his transition to professor emeritus.
Category: Lombardi Stories
-
Georgetown Honors Professor Whose Research in Breast Cancer Saved Lives
At its annual spring faculty convocation on April 8, Georgetown honored Lombardi member Marc Lippman, MD, with the President’s Award for Distinguished Scholar-Teachers, which recognizes faculty members for their excellence in teaching and scholarship. Lippman is a professor whose breakthroughs in breast cancer research have led to life-saving treatments for millions of patients.
Category: Lombardi Stories
-
Innovative Biomedical and Genetics Research Projects Net PhD Students ARCS Scholar Awards
Four doctoral candidates at Georgetown University, including MD/PhD candidate Alexander Lekan (G’26, M’28) in the Tumor Biology Program, have been named ARCS Scholars for 2025-2026. The distinction, granted by the Metropolitan Washington Chapter of the ARCS (Achievement Rewards for College Scientists) Foundation, recognizes graduate students’ valuable research contributions to the fields of science, engineering and medicine.
Category: Lombardi Stories
-
Professor Makes Strides in Pancreatic Cancer Detection and Treatment
Pancreatic cancer has the lowest survival rate of all cancers. Georgetown Lombardi member Jill Smith, MD, is working to improve the disease’s grim statistics. Over the past decade, Smith, a gastroenterologist and professor of medicine in the School of Medicine, has made discoveries in the lab that she’s working to translate to patients.
Category: Lombardi Stories
-
School of Health Student Presents Foundational Cancer Research at International Conference
School of Health student Keerthana Ramanathan (H’26) presented her team’s foundational cancer research at the 37th International Papillomavirus Conference (IPVS) in Bangkok, Thailand, in October. The IPVS is the primary international research conference for human papillomavirus (HPV).
Category: Lombardi Stories
-
Meet the 2025 BellRinger Fellows
Meet this year’s BellRinger Fellows, who worked alongside investigators at GeorgetownLombardi, gaining valuable experience and insight into how cancer research is conducted.
Category: Lombardi Stories
-
Georgetown Faculty Share Research and Explore Collaborations on Global Cervical Cancer
In June 2025, the Global Cancer Collaborative, a joint initiative between the Georgetown University Global Health Institute and Georgetown Lombardi, hosted a seminar on cervical cancer. Three presenters from Georgetown, including Lombardi member Alejandra Hurtado de Mendoza, PhD, detailed their current work, and attendees from across the university were invited to discuss new opportunities for interdisciplinary collaboration.
Category: Lombardi Stories
-
Rise in Claim Denial Rates for Cancer-Related Advanced Genetic Testing
A newly published analysis by Georgetown Lombardi member So-Yeon Kang, PhD, MBA, and colleagues has found that both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. Read more about this research.
Category: News Release
